Our bodies have a natural defence system called the immune system. The immune system protects us from disease and infection, for example by fighting bacteria or viruses that enter the body. Some people, however, are affected by autoimmune diseases: when the immune system can’t tell the difference between its own cells and foreign cells such as bacteria or viruses. As a result, the body mistakenly attacks its own normal cells causing inflammation and dysregulation in that area of the body.1
Uzpruvo has been been approved for the treatment of three different autoimmune diseases:2
Uzpruvo is currently not approved for the Ulcerative Colitis indication (since the originator still has exclusivity for this indication).
UK-UZPRU-36b | July 2024
The information on our patient website is solely intended for UK patients prescribed this medicine by a UK Healthcare Professional.
The information on our healthcare professional website is solely intended for UK healthcare professionals and contains promotional information.
I confirm I am a UK Healthcare Professional
All other visitors: Please view the Summary of Product Characteristics
Reporting of side effects. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may experience. Visit https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store to see how to report side effects.
UK-UZPRU-36n | July 2024